

23 Nov 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/rd/neurocrine-review-highlights-key-differences-between-tardive-dyskinesia-drugs-18317

20 Nov 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurocrine-biosciences-announces-publication-of-landmark-narrative-review-on-fda-approved-vmat2-inhibitors-demonstrating-unique-profile-of-ingrezza-valbenazine-capsules-302620990.html

07 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/07/3184014/0/en/AUSTEDO-deutetrabenazine-tablets-and-AUSTEDO-XR-deutetrabenazine-extended-release-tablets-Demonstrate-Positive-Real-world-Impact-with-Patients-Reporting-Improvement-in-Involuntary-.html

26 Dec 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215971

01 Jun 2024
// BUSINESSWIRE

29 May 2024
// BUSINESSWIRE